PC
PFE icon

Promus Capital’s Pfizer PFE Stock Holding History

Promus Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$63.7K Hold
2,500
– – 0.04% 140
2025
Q2 		$60.6K Hold
2,500
– – 0.04% 143
2025
Q1 		$63.4K Hold
2,500
– – 0.05% 130
2024
Q4 		$66.3K Buy
+2,500
New +$67.8K 0.05% 130

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Promus Capital's PFE Position: Q3 2025 in Review

Promus Capital held its Pfizer (PFE) position steady in Q3 2025 at 2,500 shares worth $63.7K. The position accounts for 0.04% of the portfolio, ranked #140.

Promus Capital first reported a position in PFE in Q4 2024 and has held it in 4 quarters since. The position peaked at $66.3K in Q4 2024. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Promus Capital held 2,500 shares of Pfizer worth $63.7K as of Q3 2025.
  • Promus Capital left its Pfizer share count unchanged in Q3 2025.
  • Pfizer made up 0.04% of Promus Capital's portfolio in Q3 2025, its #140 holding.
  • Promus Capital first reported a position in Pfizer in Q4 2024 and has held it in 4 quarters since.
  • Promus Capital's Pfizer position peaked at $66.3K in Q4 2024.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Promus Capital's 13F filing for Q3 2025, filed 13 Nov 2025.